 Hemostasis activation esophageal variceal sclerotherapy thrombin cirrhotics Sclerotherapy esophageal varices liver cirrhotics common procedure little possible entry sclerosants systemic circulation mixture thrombin sodium tetradecyl cefazolin effect sclerosant hemostasis parameters patients liver cirrhosis Child Classification times Blood samples injection sclerosant patients sample minutes hours treatment injection patients D-dimer t-PA levels Fibrinogen antithrombin antiplasmin thrombin/antithrombin III complex TAT levels normal ranges injection TAT D-dimer t-PA levels PC levels antithrombin antiplasmin fibrinogen concentrations unchanged TAT D-dimer levels hours data thrombin systemic circulation elevated TAT hemostasis system elevated D-dimer spite changes hemostasis system detectable thrombotic hemorrhagic complications